MedPath
TGA Approval

EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle (431932)

431932

EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle

Celltrion Healthcare Australia Pty Ltd

March 31, 2025

Medicine

Medicine

Active

Registered

Product Information

Product Information

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2025-PI-01507-1

Active Ingredients

Aflibercept

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle (431932) - TGA 批准文号 | MedPath